Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for Isolated Congenital Anomalies When Non‐Invasive Screening Is Performed
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Ethan Lorence und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Human Genetics of the College of Medicine at the University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: In Situ Hybridization, Fluorescence, Congenital Abnormalities, Noninvasive Prenatal Testing. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objective
Current inclusion criteria for fetal surgery at most centers include the absence of multiple major anomalies and a normal chromosome analysis or fluorescence in situ hybridization (FISH) for aneuploidy. We evaluated the concordance of FISH with non‐invasive screening methodologies to determine if invasive genetic testing provides additional information on fetal surgery candidacy.
Methods
A retrospective chart review was performed on 963 pregnancies evaluated for fetal surgery at the Cincinnati Children's Hospital Fetal Care Center between July 1, 2018 and July 31, 2023 for genetic testing results, fetal imaging, and surgical candidacy.
Results
FISH was concordant with screening results in 100% of pregnancies whose imaging and cell‐free fetal DNA screening suggested a fetus at low risk for trisomy 21, trisomy 18, trisomy 13, and sex chromosome aneuploidies. Pregnancies with multiple congenital anomalies were significantly more likely to have abnormal genetic testing compared to pregnancies with isolated anomalies (52% vs. 17%, P = 0.0009).
Conclusions
In this study cohort, FISH did not provide additional information for the risk‐benefit analysis of fetal surgery and introduced additional risk to the pregnancy due to the need for invasive fetal DNA collection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Division of Human Genetics of the College of Medicine at the University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Human Genetics at the Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Precision Medicine Institute at TriHealth, Cincinnati, Ohio, USA.
- Cincinnati Children's Fetal Care Center, Cincinnati, Ohio, USA.
- Cincinnati Children's Hospital Medical Center, Division of Neonatology and Pulmonary Biology, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Ethan Lorence, Katelyn Seither, Kara B Markham
Zitieren
APA
Lorence, E., Seither, K., He, H., Markham, K. B., & Wong, B. (2026). Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for Isolated Congenital Anomalies When Non‐Invasive Screening Is Performed. Prenatal Diagnosis. https://doi.org/10.1002/pd.70068
Vancouver
Lorence E, Seither K, He H, Markham KB, Wong B. Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for Isolated Congenital Anomalies When Non‐Invasive Screening Is Performed. Prenatal Diagnosis. 2026. doi:10.1002/pd.70068
BibTeX
@article{Lorence2026,
author = {Lorence, Ethan and Seither, Katelyn and He, Hua and Markham, Kara B and Wong, Beatrix},
title = {Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for Isolated Congenital Anomalies When Non‐Invasive Screening Is Performed},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70068}
}
EUVIMED